Hyalex Orthopaedics, developer of HYALEX synthetic polymer that is designed to mimic hyaline cartilage, grew its original Series A funding to US $33MM.Â
SpineEX was issued its second U.S. patent, addressing a novel mechanism to adjust posterior and anterior sides of an interbody fusion device independently of each other.Â
SpineEX gained additional FDA clearance for the Sagittae Lateral Lumbar Interbody Fusion system, covering new instrumentation and an updated surgical technique.
Bone Biologics received regulatory approval in Australia for a multicenter pilot clinical trial to evaluate NELL-1/DBX® in the treatment of degenerative disc disease.